Figures & data
Figure 1 Effect of L-arginine (20 mg/kg) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ significantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b, differ significantly (p < 0.05) when compared against the respective (dH2O)-pretreated group.
![Figure 1 Effect of L-arginine (20 mg/kg) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ significantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b, differ significantly (p < 0.05) when compared against the respective (dH2O)-pretreated group.](/cms/asset/d4f44191-a62a-4bb3-a8fc-16a0d8365a5e/iphb_a_179792_f0001_b.gif)
Figure 2 Effect of L-NAME (20 mg/kg) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ significantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b, differ significantly (p < 0.05) when compared against the respective (dH2O)-pretreated group.
![Figure 2 Effect of L-NAME (20 mg/kg) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ significantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b, differ significantly (p < 0.05) when compared against the respective (dH2O)-pretreated group.](/cms/asset/fc5c89d2-4c8d-43bc-a827-b1e27d0ce079/iphb_a_179792_f0002_b.gif)
Figure 3 Effect of MB (20 mg/kg) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ significantly (p < 0.05) when compared against the the control [(dH2O + dH2O)-treated] group; b, differ significantly (p < 0.05) when compared against the respective (dH2O)-pretreated group.
![Figure 3 Effect of MB (20 mg/kg) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ significantly (p < 0.05) when compared against the the control [(dH2O + dH2O)-treated] group; b, differ significantly (p < 0.05) when compared against the respective (dH2O)-pretreated group.](/cms/asset/559321d1-e063-4aee-9e88-4620d2bbb290/iphb_a_179792_f0003_b.gif)
Figure 4 Effects of L-arginine, L-NAME, or its combination (L-arginine + L-NAME) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ signifcantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b,c,d, differ signifcantly (p < 0.05) when compared against the respective [(dH2O)-pretreated] group; e, differ signifcantly (p < 0.05) when compared against the respective [(L-arginine)-pretreated] group.
![Figure 4 Effects of L-arginine, L-NAME, or its combination (L-arginine + L-NAME) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ signifcantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b,c,d, differ signifcantly (p < 0.05) when compared against the respective [(dH2O)-pretreated] group; e, differ signifcantly (p < 0.05) when compared against the respective [(L-arginine)-pretreated] group.](/cms/asset/415f8cc9-6852-43f7-a2b9-acc1bc298afd/iphb_a_179792_f0004_b.gif)
Figure 5 Effects of L-arginine, MB, or its combination (L-arginine + MB) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ signifcantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b,c,d, differ signifcantly (p < 0.05) when compared against the respective [(dH2O)-pretreated] group; e, differ signifcantly (p < 0.05) when compared against the respective [(L-arginine)-pretreated] group.
![Figure 5 Effects of L-arginine, MB, or its combination (L-arginine + MB) on ASA and AECO antinociception assessed by abdominal constriction test. a, differ signifcantly (p < 0.05) when compared against the control [(dH2O + dH2O)-treated] group; b,c,d, differ signifcantly (p < 0.05) when compared against the respective [(dH2O)-pretreated] group; e, differ signifcantly (p < 0.05) when compared against the respective [(L-arginine)-pretreated] group.](/cms/asset/8b979bee-1499-4735-ae22-e9811e1dd5cc/iphb_a_179792_f0005_b.gif)